User:Tkosm/sandbox

CareAcross is a digital health company focusing on cancer. It does not provide medical advice, and its services are not intended to replace medical advice.

History
CareAcross was founded in 2013 as “Care Across Ltd” in London. The company’s mission is to “provide patients with personalised services to help improve their quality of life, while collaborating with the industry in a way that respects patients’ privacy”. The initial and current focus of the company has been the cancer therapeutic area, armed with the strong expertise of the company’s Chief Medical Officer (Dr Paris Kosmidis, also a past President of the European Society for Medical Oncology).

The company launched an online private and anonymous patient community for cancer patients to exchange “Stories” and tips for their condition, in 2015, during its tenure in the MassChallenge UK accelerator. The patient insights captured led the company to shift its focus from broad communities to extreme personalisation. More specifically, in 2017, the company launched its first personalised support service for breast cancer patients in the UK, and subsequently addressed other types of cancer, in multiple countries (with content translated and localised by native speakers).

Patient Services
Patients receive 100% tailored content based on their diagnosis, treatment, comorbidities, side-effects, etc. The goal is not to replace the clinician but improve patients’ abilities to self-care when they are not in the clinic. More specifically, the services address areas including:
 * Side-effects management
 * Nutrition
 * Exercise
 * Weight control
 * Depression
 * Anxiety
 * Supplements use
 * and more.

The content provided is original and is based on scientific evidence, peer-reviewed publications and guidelines.

Industry Services
The company works with the industry (including pharmaceutical, research, diagnostics, devices, insurance and other companies) towards services like the following:
 * Patient Engagement
 * Real World Evidence (RWE)
 * Patient Reported Outcomes (PROs)
 * clinical trial recruitment
 * and other.

European Commission Research
Care Across Ltd is a participant in the following Horizon2020 projects:
 * CrowdHEALTH: Collective wisdom driving public health policies (Grant Agreement no. 727560)
 * ASCAPE: Artificial intelligence Supporting CAncer Patients across Europe (Grant Agreement no. 875351)
 * ONCORELIEF: A digital guardian angel enhancing cancer patient’s wellbeing and health status improvement following treatment (Grant Agreement no. 875392).